Patients undergoing venous arterial fistula implantation.
Conditions
Interventions
Intervention 1: Intervention group 1: Dexamidomethidine administration (bolus dose of 0.4 µg / kg intravenously over 10 minutes and maintenance dose of 0.5 to 1.00 µg / kg / min). Its manufacturer is
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
19 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age group 19 to 60 years Patients with stable hemodynamic status
Exclusion criteria
Exclusion criteria: Patients with a history of cardiovascular abnormalities Patients with a history of chronic diseases such as liver disease Patients with a history of allergies to anesthetics, including opioids Patients with a history of opium use Pregnant or lactating women Recent respiratory tract infection Severe bronchopulmonary disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score. Timepoint: At the moment after the operation and also every half an hour, up to two hours after the operation. Method of measurement: Use of Visual Analogue Scale (VAS) scoring system. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: After surgery. Method of measurement: Observation.;Hypertension. Timepoint: After surgery. Method of measurement: Mercury barometer.;Oxygen saturation. Timepoint: After surgery. Method of measurement: Pulse oximetry.;Tachycardia and bradycardia. Timepoint: After surgery. Method of measurement: Monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Maleki
Iran University of Medical Sciences
Outcome results
None listed